300 related articles for article (PubMed ID: 30066490)
21. Prevalence of sarcopenia in older patients with colorectal cancer.
Broughman JR; Williams GR; Deal AM; Yu H; Nyrop KA; Alston SM; Gordon BB; Sanoff HK; Muss HB
J Geriatr Oncol; 2015 Nov; 6(6):442-5. PubMed ID: 26365898
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
23. Low total psoas area as scored in the clinic setting independently predicts midterm mortality after endovascular aneurysm repair in male patients.
Thurston B; Pena GN; Howell S; Cowled P; Fitridge R
J Vasc Surg; 2018 Feb; 67(2):460-467. PubMed ID: 28843791
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients.
Cespedes Feliciano EM; Popuri K; Cobzas D; Baracos VE; Beg MF; Khan AD; Ma C; Chow V; Prado CM; Xiao J; Liu V; Chen WY; Meyerhardt J; Albers KB; Caan BJ
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1258-1269. PubMed ID: 32314543
[TBL] [Abstract][Full Text] [Related]
25. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
[TBL] [Abstract][Full Text] [Related]
26. Use of 3D-CT-derived psoas major muscle volume in defining sarcopenia in colorectal cancer.
Takahashi M; Sakamoto K; Kogure Y; Nojiri S; Tsuchiya Y; Honjo K; Kawai M; Ishiyama S; Sugimoto K; Nagakari K; Tomiki Y
BMC Cancer; 2024 Jun; 24(1):741. PubMed ID: 38890682
[TBL] [Abstract][Full Text] [Related]
27. Cut-off values of skeletal muscle index and psoas muscle index at L3 vertebra level by computerized tomography to assess low muscle mass.
Bahat G; Turkmen BO; Aliyev S; Catikkas NM; Bakir B; Karan MA
Clin Nutr; 2021 Jun; 40(6):4360-4365. PubMed ID: 33516603
[TBL] [Abstract][Full Text] [Related]
28. The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS).
Brown JC; Caan BJ; Meyerhardt JA; Weltzien E; Xiao J; Cespedes Feliciano EM; Kroenke CH; Castillo A; Kwan ML; Prado CM
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):664-672. PubMed ID: 29766660
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of using chest computed tomography (CT) imaging at the first lumbar vertebra (L1) level to assess skeletal muscle mass: a retrospective study.
Liu S; Han X; Li J; Xie X; Yang Y; Jiang W; Liu L; Liu Z
PeerJ; 2023; 11():e16652. PubMed ID: 38099314
[TBL] [Abstract][Full Text] [Related]
30. Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study.
Kong M; Geng N; Zhou Y; Lin N; Song W; Xu M; Li S; Piao Y; Han Z; Guo R; Yang C; Luo N; Wang Z; Jiang M; Wang L; Qiu W; Li J; Shi D; Li R; Cheung EC; Chen Y; Duan Z
Clin Nutr; 2022 Feb; 41(2):396-404. PubMed ID: 34999334
[TBL] [Abstract][Full Text] [Related]
31. A Novel Use for Pelvic MRI Scans to Estimate Lean Body Mass and Screen for Sarcopenia in Patients With Rectal Cancer.
Melucci AD; Lynch OF; Loria A; Mustian KM; Dunne RF; Temple LK; Fleming FJ
Dis Colon Rectum; 2023 Mar; 66(3):e122-e126. PubMed ID: 36649180
[TBL] [Abstract][Full Text] [Related]
32. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
[TBL] [Abstract][Full Text] [Related]
33. Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia.
Pigneur F; Di Palma M; Raynard B; Guibal A; Cohen F; Daidj N; Aziza R; El Hajjam M; Louis G; Goldwasser F; Deluche E
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1613-1620. PubMed ID: 37203274
[TBL] [Abstract][Full Text] [Related]
34. Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study).
Caan BJ; Meyerhardt JA; Kroenke CH; Alexeeff S; Xiao J; Weltzien E; Feliciano EC; Castillo AL; Quesenberry CP; Kwan ML; Prado CM
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1008-1015. PubMed ID: 28506965
[No Abstract] [Full Text] [Related]
35. Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.
Takeda Y; Akiyoshi T; Matsueda K; Fukuoka H; Ogura A; Miki H; Hiyoshi Y; Nagasaki T; Konishi T; Fujimoto Y; Fukunaga Y; Ueno M
PLoS One; 2018; 13(4):e0195406. PubMed ID: 29630652
[TBL] [Abstract][Full Text] [Related]
36. The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer.
Xiao J; Caan BJ; Cespedes Feliciano EM; Meyerhardt JA; Kroenke CH; Baracos VE; Weltzien E; Kwan ML; Alexeeff SE; Castillo AL; Prado CM
Am J Clin Nutr; 2019 Mar; 109(3):615-625. PubMed ID: 30850836
[TBL] [Abstract][Full Text] [Related]
37. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
[TBL] [Abstract][Full Text] [Related]
38. Racial differences in body composition and survival among older adults with gastrointestinal malignancies.
Aleixo GFP; Hess DL; Fowler ME; Giri S; Williams GR
J Geriatr Oncol; 2024 May; 15(4):101747. PubMed ID: 38513310
[TBL] [Abstract][Full Text] [Related]
39. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
[No Abstract] [Full Text] [Related]
40. Comparison of CT derived body composition at the thoracic T4 and T12 with lumbar L3 vertebral levels and their utility in patients with rectal cancer.
Arayne AA; Gartrell R; Qiao J; Baird PN; Yeung JM
BMC Cancer; 2023 Jan; 23(1):56. PubMed ID: 36647027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
